Retina

SECO hosted its 2022 annual meeting March 9-13 at the Ernest N. Morial Convention Center with a LIVE CE virtual meeting available to online attendees.

Mohammad Rafieetary, OD, FAAO, offers a sneak peek at the latest (and fake!) news in retina.

Mohammad Rafieetary, OD, FAAO, shares highlights from his SECO 2022 presentation titled "Image-in that! Scanning for retinal disease."

OCT showed inner retinal hyperreflectivity, diffuse retinal thickening with intraretinal fluid, and a serous macular detachment.

Evaluating accuracy of biometry is paramount in eyes with history of retinal pathology

As consistent use of digital devices remains a fact of life for people of virtually all ages, consider this expert advice

Faricimab is now the first and only FDA-approved drug to target two distinct pathways known to cause retinal disease that may lead to vision loss.

Timing is key in reducing the risk of developing vision loss or blindness.

Positive one-year results of Genentech’s phase III trials analyzing faricimab for treatment of wet AMD and DME were released today.

Expand your business by administering injectable treatments.

ASCENT, RegenXBio’s Phase III clinical trial conducted in partnership with AbbVie, is expected to enroll patients in the United States and Canada, with pivotal trials expected to support BLA submission for RGX-314 in 2024.

A review of monitoring guidelines, risk assessment, and treatment algorithms.

Patients undergoing injections during the COVID-19 pandemic experienced increases in bacterial contamination of the periocular area of their surgical face masks when the masks were worn for longer than 4 hours, report Spanish researchers.

Dr. Kerry Gelb speaks with Dr. Jay M. Hainie in the second part of their discussion on diabetes of the eye!

Evolving techniques may offer better long-term outcomes for patients

Roundtable of experts discuss impact, management of retinal disease.

Trauma evaluation leads to diagnosis, treatment for commotio retinae

Diabetic papillitis is relatively rare, found in type 1 and 2 diabetes patients

During a presentation at the American Academy of Optometry 2021 annual meeting in Boston, Sherry Bass, OD, FAAO, described for attendees the circuitous path that clinicians have had to negotiate to establish a diagnosis in patients with inherited retinal diseases, how that path has become more straightforward, and examples of how genetic testing can help in the diagnosis of IRDs in tricky cases.

During a presentation at the American Academy of Optometry 2021 annual meeting in Boston, Micaela Gobeille, OD, MS, FAAO, discussed keys to the successful management of retinitis pigmentosa.

The FDA has approved XIPERE for the treatment of macular edema associated with uveitis

Remain vigilant to recurrences to apply potential treatments

Practitioners spend more time diagnosing glaucoma or diabetic retinopathy than AMD